On Medical Grounds Podcast

Medavera does not utilize AI to develop our content because of the risks associated with inaccuracies, bias, and incomplete information.

Due to these same issues, ACCME has produced guidance for the responsible use of AI in accredited programs. While the accreditor suggests certain uses of AI may be relevant for planning, evaluation, and organizational purposes, the message is clear that if AI is used to develop program content, the new guidance should be implemented and documented.

The full guidance document is available at the link below:https://zurl.co/9vzGY

We had the honor of working with a great group of collaborators on this paper. Thank you all for your insights and hard work!
https://zurl.co/i1AGD

Comparative evaluation of Savanna HSV 1+2/VZV multiplex assay and Simplexa HSV 1&2 and VZV direct kits for rapid molecular detection of HSV-1, HSV-2, and VZV | Microbiology Spectrum Lesion-causing viruses, herpes simplex (HSV-1 and HSV-2) and varicella-zoster virus (VZV), are common and difficult to distinguish clinically. Each can be found over any area of the body but have different treatment regimens and considerations for infectivity and future outbreak management. Laborato...

New publication alert! A new paper has been published on the performance of the FDA-approved Lumipulse G pTau 217/β-Amyloid (Aβ) 1-42 plasma ratio test. The data show the test's efficacy in differentiating amyloid-positive and amyloid-negative pathology in a selection of patients across the cognitive impairment spectrum. OMG interviewed one of the authors of the paper, Dr. Francesca De Simone, along with Alzheimer's specialist Dr. Douglas Galasko on the benefits of plasma testing in patients with cognitive impairment. Check out the paper and podcast below!

Publication: https://zurl.co/6NdjI Podcast with Dr. Douglas Galasko and Dr. Francesca De Simone: https://zurl.co/DC2PW